ORTEXORTEX News
Tracking CIGI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CI
Trader NoteCIGI

Colliers Holds Steady While Peers Slide, Activist Stake Grows

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 28 Oct 2026, 20:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CIGI is one of the calmer names in its peer group this week, even as a Schedule 13D filing adds a new layer of attention to the stock.

Among the closest peers, CBRE dropped nearly 9.4% over the past week and JLL fell 2.9%. CWK was an exception, gaining 4.9%. Against that backdrop, CIGI's flat weekly move, up just 0.07% to CAD 130.88, looks relatively firm. Short interest is below 1% of the free float, at roughly 0.98%, but it has moved sharply: up 57% in one week from a low base, driven mainly by a step-up that started around October 19. The absolute level remains too small to flag as a crowding risk, with fewer than 490,000 shares short and availability for new borrows running at 460%, meaning there are more than four shares available to lend for every one already borrowed. Cost to borrow is 0.75%, barely above a risk-free lending rate. The borrow market is giving no distress signal.

The activist register is more newsworthy. Benjamin Stein holds 6.6% of CIGI's shares, up from 5.1% previously, and filed a Schedule 13D amendment on September 28, a form that explicitly signals active intent rather than passive ownership. That is the single highest-signal entry in this week's snapshot. Stein is also listed as a director on CIGI's insider register, giving him both board access and an escalating economic position. As with all 13D/G disclosures, the stake is as last reported around the 5% threshold, and a holder can fall below 5% without filing again. Separately, Spruce House Investment Management added nearly 490,000 shares in the period to September 28, bringing its position to 6.3% of shares outstanding. T. Rowe Price added 647,000 shares through September 30. The largest single holder remains founder and CEO Jay Hennick at 13.6%, a concentration that tends to limit the scope for contested activism.

Valuation multiples are undemanding in absolute terms. The trailing PE is 11.4x and EV/EBITDA is 8.8x, both little changed over the past 30 days. The earnings yield factor ranks in the 58th percentile, and the short score of 35.6 is mid-range, consistent with the low short interest level. Analyst data in the system is stale, last updated in August 2023, so no current Street consensus is available.

The next earnings release is set for November 3. Recent prints have produced small moves: a 3% gain in the five days following the July 31 event, and a 2.7% one-day decline and a 2.7% five-day decline after the prior quarter. The Stein 13D and the pace of institutional accumulation are the factors to track into that date, alongside whether short interest continues its recent climb from a very low base.

Stocks in this article

See the live data behind this article on ORTEX.

Open CIGI on ORTEX →

How this article was generated

Generated
28 Oct 2026, 20:13
Data as of
28 Oct 2026, 20:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.